JP2014507482A5 - - Google Patents

Download PDF

Info

Publication number
JP2014507482A5
JP2014507482A5 JP2013557912A JP2013557912A JP2014507482A5 JP 2014507482 A5 JP2014507482 A5 JP 2014507482A5 JP 2013557912 A JP2013557912 A JP 2013557912A JP 2013557912 A JP2013557912 A JP 2013557912A JP 2014507482 A5 JP2014507482 A5 JP 2014507482A5
Authority
JP
Japan
Prior art keywords
subject
lung
safakutan
bets
msc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013557912A
Other languages
English (en)
Other versions
JP6204830B2 (ja
JP2014507482A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/028524 external-priority patent/WO2012125471A1/en
Publication of JP2014507482A publication Critical patent/JP2014507482A/ja
Publication of JP2014507482A5 publication Critical patent/JP2014507482A5/ja
Application granted granted Critical
Publication of JP6204830B2 publication Critical patent/JP6204830B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (1)

  1. 肺疾患を有するか、またはこれを発症する危険性があるヒト対象における使用のための、肺への送達のために処方された、単離されたヒト間葉系幹細胞(MSC)エキソソームの有効量および肺サーファクタントを含む、医薬組成物であって、前記対象が4週齢未満である、前記医薬組成物。
JP2013557912A 2011-03-11 2012-03-09 間葉系幹細胞エキソソームに関連する方法および組成物 Active JP6204830B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161451981P 2011-03-11 2011-03-11
US61/451,981 2011-03-11
PCT/US2012/028524 WO2012125471A1 (en) 2011-03-11 2012-03-09 Methods and compositions relating to mesenchymal stem cell exosomes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017168158A Division JP6524162B2 (ja) 2011-03-11 2017-09-01 間葉系幹細胞エキソソームに関連する方法および組成物

Publications (3)

Publication Number Publication Date
JP2014507482A JP2014507482A (ja) 2014-03-27
JP2014507482A5 true JP2014507482A5 (ja) 2016-09-01
JP6204830B2 JP6204830B2 (ja) 2017-09-27

Family

ID=45852770

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013557912A Active JP6204830B2 (ja) 2011-03-11 2012-03-09 間葉系幹細胞エキソソームに関連する方法および組成物
JP2017168158A Active JP6524162B2 (ja) 2011-03-11 2017-09-01 間葉系幹細胞エキソソームに関連する方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017168158A Active JP6524162B2 (ja) 2011-03-11 2017-09-01 間葉系幹細胞エキソソームに関連する方法および組成物

Country Status (8)

Country Link
US (3) US9901600B2 (ja)
EP (1) EP2683389B1 (ja)
JP (2) JP6204830B2 (ja)
KR (2) KR101947699B1 (ja)
CN (2) CN109432126B (ja)
CA (1) CA2829586C (ja)
ES (1) ES2629502T3 (ja)
WO (1) WO2012125471A1 (ja)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
ES2629502T3 (es) * 2011-03-11 2017-08-10 Children's Medical Center Corporation Métodos y composiciones relacionados con exosomas de células madre mesenquimales
ITRM20110403A1 (it) * 2011-07-28 2013-01-29 Ospedale Pediatrico Bambino Gesu Microvescicole isolate da cellule mesenchimali come agenti immunosoppressori.
US9427450B2 (en) * 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
GB201202319D0 (en) 2012-02-10 2012-03-28 Orbsen Therapeutics Ltd Stromal stem cells
EP3563859B1 (en) 2012-08-13 2021-10-13 Cedars-Sinai Medical Center Cardiosphere-derived exosomes for tissue regeneration
AU2013360026B2 (en) * 2012-12-12 2018-06-21 Mesoblast, Inc. Methods of treating or preventing respiratory conditions
CN103865873B (zh) * 2012-12-12 2017-04-05 中国医学科学院基础医学研究所 亚全能干细胞分泌的外来体及其应用
PT3527670T (pt) 2013-03-15 2024-01-18 Beth Israel Deaconess Medical Ct Inc Biogénese de mirna em exossomas para diagnóstico e terapia
CN113648323A (zh) 2013-06-05 2021-11-16 再生疗法有限公司 用于哺乳动物物种中诱导性组织再生的组合物和方法
WO2015016761A2 (en) * 2013-08-01 2015-02-05 Isletone Ab Mscs in the treatment of inflammatory pulmonary diseases
GB201317887D0 (en) 2013-10-09 2013-11-20 Reneuron Ltd Product
CN104694466A (zh) * 2013-12-06 2015-06-10 山西医科大学 间充质干细胞来源的胞外体制备及在急性肺损伤中的应用
WO2015088286A1 (ko) 2013-12-12 2015-06-18 사회복지법인 삼성생명공익재단 줄기세포 유래 엑소좀을 유효성분으로 포함하는 뇌혈관 질환 치료용 약학적 조성물
US11078462B2 (en) 2014-02-18 2021-08-03 ReCyte Therapeutics, Inc. Perivascular stromal cells from primate pluripotent stem cells
US9919011B2 (en) 2014-03-18 2018-03-20 Samsung Life Public Welfare Foundation Method for treating an inflammatory brain disease comprising administering a stem cell-derived exosome
US10624929B2 (en) * 2014-05-18 2020-04-21 Children's Medical Center Corporation Methods and compositions relating to exosomes
WO2015191545A1 (en) * 2014-06-09 2015-12-17 University Of Washington Methods of protection against ischemia reperfusion injury
CN106573017B (zh) * 2014-06-30 2021-06-11 泰根尼克斯独资有限公司 用于治疗脓毒症的间充质基质细胞
US10240127B2 (en) 2014-07-03 2019-03-26 ReCyte Therapeutics, Inc. Exosomes from clonal progenitor cells
US10918669B2 (en) 2014-07-25 2021-02-16 Recellerate, Inc. Methods of treating exercise-induced pulmonary hemorrhage
JP6878274B2 (ja) 2014-10-03 2021-05-26 シーダーズ−サイナイ・メディカル・センターCedars−Sinai Medical Center 筋ジストロフィーの処置における心筋球由来細胞およびこのような細胞によって分泌されたエキソソーム
WO2016057560A1 (en) * 2014-10-06 2016-04-14 Cedars-Sinai Medical Center Polarization of macrophages to a healing phenotype by cardiosphere-derived cells and by the exosomes secreted by such cells
WO2016072821A1 (ko) * 2014-11-07 2016-05-12 한양대학교 에리카산학협력단 줄기세포 유래 엑소좀을 함유하는 지방세포 분화유도, 지방조직 재생, 피부 미백 또는 주름개선용 조성물
CN118161529A (zh) * 2014-11-07 2024-06-11 胞外体干细胞株式会社 用于成脂分化诱导、脂肪组织再生、皮肤美白或改善皱纹的包含干细胞来源外泌体的组合物
US20160160181A1 (en) * 2014-12-03 2016-06-09 Capricor Thera[eitocs, Inc. Processes for producing exosomes in reduced oxygen culture conditions
CN104560877B (zh) * 2014-12-18 2017-07-28 福州市传染病医院 一种快速分离细胞外吐小体的方法
US20180264047A1 (en) * 2014-12-24 2018-09-20 Ube Industries, Ltd. Cell culture supernatant fluid derived from lung tissue
US10342830B2 (en) * 2015-01-05 2019-07-09 Gary M. Petrucci Methods and materials for treating lung disorders
US9687511B2 (en) 2015-03-06 2017-06-27 Vivex Biomedical, Inc. Acellular biologic composition and method of manufacture
US11160904B2 (en) * 2017-05-09 2021-11-02 Vivex Biologies Group, Inc. Biological composition in a protectant shroud and methods
KR101566450B1 (ko) * 2015-04-03 2015-11-05 (유)스템메디케어 중간엽 줄기세포에서 단백질의 대량 생산 방법
MX2017013852A (es) 2015-04-28 2019-04-15 Texas A & M Univ Sys Produccion escalable de vesiculas extracelulares estandarizadas, preparaciones de vesiculas extracelular y usos de estos.
AU2016276942B2 (en) * 2015-06-10 2022-08-25 Children's National Medical Center Adipocyte-derived exosomes, and compositions, kits, and methods of using the same for detection and screening
EP3307890A1 (en) 2015-06-10 2018-04-18 Board of Regents, The University of Texas System Use of exosomes for the treatment of disease
EP3307286B1 (en) * 2015-06-12 2023-01-11 Hudson Institute of Medical Research Allogeneic mammalian amniotic exosomes for treating a fibrotic disease
US11077147B2 (en) * 2015-07-20 2021-08-03 Vivex Biologics Group, Inc. Acellular biologic composition and method of manufacture
RS64469B1 (sr) * 2015-07-31 2023-09-29 Exotropin Llc Kompozicije egzozoma i postupci za njihovu pripremu i primenu za regulisanje i kondicioniranje kože i kose
WO2017123662A1 (en) 2016-01-11 2017-07-20 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
WO2017122095A1 (en) * 2016-01-15 2017-07-20 Orbsen Therapeutics Limited Sdc-2 exosome compositions and methods of isolation and use
EP3407844A4 (en) 2016-01-29 2019-10-16 Qool Therapeutics, Inc. AEROSOLISATION OF STEM CELLS OR STEM CELL DERIVATIVES FOR PULMONARY ADMINISTRATION
KR101843634B1 (ko) * 2016-04-15 2018-03-30 사회복지법인 삼성생명공익재단 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 만성폐질환 치료용 조성물
US11351200B2 (en) 2016-06-03 2022-06-07 Cedars-Sinai Medical Center CDC-derived exosomes for treatment of ventricular tachyarrythmias
CA3027970A1 (en) * 2016-06-17 2017-12-21 United Therapeutics Corporation Extracellular vesicles with enhanced potency
US10946047B2 (en) * 2016-06-17 2021-03-16 United Therapeutics Corporation Extracellular vesicles with enhanced potency
AU2017305067B2 (en) * 2016-08-03 2022-11-03 Hiroshi Yabuki Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells
EP3494978A4 (en) * 2016-08-03 2020-03-11 National University Corporation Nagoya University IMPROVEMENT AND TREATMENT OF CHRONIC PULMONARY DISEASES USING PLURIPOTENT STEM CELLS
JP6882450B2 (ja) * 2016-08-05 2021-06-02 株式会社エキソステムテックExostemtech Co.,Ltd. 脂肪由来幹細胞から抽出されたエキソソームを有効成分として含む肺線維症の予防または治療用の組成物
EP3515459A4 (en) 2016-09-20 2020-08-05 Cedars-Sinai Medical Center CELLS DERIVED FROM CARDIOSPHERES AND THEIR EXTRACELLULAR VESICLES TO DELAY OR REVERSE AGING AND AGE-RELATED DISORDERS
CN110072534A (zh) * 2016-10-13 2019-07-30 Vbc控股有限责任公司 外泌体的医学应用
WO2018071682A1 (en) * 2016-10-13 2018-04-19 Vbc Holdings Llc Anti-inflammatory exosomes from inflamed cells or tissues
AU2018228352A1 (en) * 2017-02-28 2019-09-26 Centre Hospitalier Régional Universitaire De Nancy Mesenchymal stem cells obtained from Wharton's jelly for the treatment of sepsis
US20180291336A1 (en) * 2017-04-07 2018-10-11 Robert John Petcavich Method of manufacturing and purifying exosomes from non-terminally differentiated cells
US11759482B2 (en) 2017-04-19 2023-09-19 Cedars-Sinai Medical Center Methods and compositions for treating skeletal muscular dystrophy
US11692172B2 (en) * 2017-06-26 2023-07-04 Mackay Memorial Hosptal Formulation comprising extracellular vesicles, method for producing the same, and uses thereof
KR20190011213A (ko) * 2017-07-24 2019-02-01 한양대학교 에리카산학협력단 줄기세포로부터 추출된 엑소좀을 유효성분으로 포함하는 골다공증 예방 또는 치료용 조성물
US20220023347A9 (en) * 2017-08-15 2022-01-27 Children's Medical Center Corporation Purified mesenchymal stem cell exosomes and uses thereof
US11471559B2 (en) * 2017-11-20 2022-10-18 Vivex Biologics Group, Inc. Bioenergetic bone
EP3727351A4 (en) 2017-12-20 2021-10-06 Cedars-Sinai Medical Center MODIFIED EXTRACELLULAR VESICLES FOR IMPROVED TISSUE DELIVERY
WO2019212305A1 (ko) * 2018-05-04 2019-11-07 사회복지법인 삼성생명공익재단 기관지 폐 이형성증 (bpd) 예방 또는 치료용 물질 스크리닝 방법
WO2019231562A1 (en) * 2018-05-30 2019-12-05 Direct Biologics Llc A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use
JP7363003B2 (ja) * 2018-06-11 2023-10-18 ヘルス、アンド、バイオテック、フランス(アッシュ、アンド、ベー、フランス) 間葉系幹細胞由来細胞外小胞
EP4344739A3 (en) * 2018-06-29 2024-05-29 North Carolina State University Therapeutic lung repair by inhalation of lung spheroid cell-secreted factors
AU2019312212A1 (en) * 2018-07-24 2021-03-11 Atta Behfar Compositions and methods involving transforming extracellular vesicles
MX2021001574A (es) 2018-08-10 2021-07-15 Omnispirant Ltd Vesiculas extracelulares para inhalacion.
EP3879980A4 (en) * 2018-11-15 2022-08-24 Washington University EXTRACELLULAR VESICLES DERIVED FROM STEM CELLS AND METHODS OF USE THEREOF
JP7372518B2 (ja) * 2019-06-27 2023-11-01 国立大学法人山口大学 骨髄由来間葉系幹細胞の培養方法
US20210052641A1 (en) * 2019-08-23 2021-02-25 United Therapeutics Corporation Pre-conditioned extracellular vesicles and methods of production
CN110777113B (zh) * 2019-09-10 2021-09-24 中山大学 一种用于日本血吸虫感染治疗的间质干细胞处理方法
KR20220131902A (ko) * 2019-12-04 2022-09-29 유나이티드 쎄러퓨틱스 코포레이션 세포외 소포 및 이의 용도
CN113384597A (zh) * 2020-03-13 2021-09-14 西比曼生物科技(上海)有限公司 含人体细胞衍生的细胞膜外囊泡的雾化吸入制剂、制法及其应用
CN111346110A (zh) * 2020-03-17 2020-06-30 遵义医学院附属医院 间充质干细胞上清液在制备治疗肺细胞损伤制剂中的应用
AU2021306640A1 (en) * 2020-07-09 2023-02-09 Exo Biologics Sa Process for the manufacturing of protein-associated extracellular vesicles
US20230248773A1 (en) 2020-07-09 2023-08-10 Exo Biologics Sa Extracellular Vesicles and Compositions Thereof
CN112043686A (zh) * 2020-09-21 2020-12-08 沈阳三禾生物科技有限公司 脐带间充质干细胞外泌体雾化液在制备治疗哮喘产品中的应用
CN112007049A (zh) * 2020-09-21 2020-12-01 济南磐升生物技术有限公司 一种用于治疗膝骨关节炎的干细胞外泌体组合物
AU2021375735A1 (en) * 2020-11-06 2023-06-08 Aatec Medical Gmbh A composition comprising extra-cellular vesicles from mesenchymal stem cells and alpha-1 antitrypsin for the treatment of viral infections
EP3995130A1 (en) * 2020-11-06 2022-05-11 JunctuCell Biomed Manufacturing GmbH A composition comprising extra-cellular vesicles from mesenchymal stem cells and alpha-1 antitrypsin for the treatment of viral infections
JP2023550328A (ja) * 2020-11-26 2023-12-01 サムスン ライフ パブリック ウェルフェア ファウンデーション トロンビン処理幹細胞に由来したエクソソームを含む感染性疾患治療用組成物
CN112675203A (zh) * 2021-02-08 2021-04-20 瑞太生物科技(沈阳)有限公司 一种细胞来源的外泌体在制备治疗哮喘和/或肺纤维化生物制剂中的应用
WO2023044443A1 (en) 2021-09-16 2023-03-23 Life Technologies Corporation Cell expansion methods and compositions for use therein

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
FR2766205B1 (fr) * 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US20030221199A1 (en) * 1998-10-20 2003-11-27 Whitsett Jeffrey A. Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
US20040214783A1 (en) * 2002-05-08 2004-10-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
WO2006110582A1 (en) 2005-04-08 2006-10-19 Xcyte Therapies, Inc. Compositions and methods for the treatment of burns and sepsis
US8962318B2 (en) 2005-09-02 2015-02-24 Agency For Science, Technology And Research Method of deriving mesenchymal stem cells from ES cells using FGF2
US20090274665A1 (en) * 2006-04-27 2009-11-05 Cell Therapy Technologies, Inc. Stem Cells For Treating Lung Diseases
JP2010500047A (ja) 2006-08-15 2010-01-07 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ 間葉系幹細胞馴化培地
PT2578081E (pt) 2006-10-11 2016-06-17 Massachusetts Inst Technology Composições, métodos e dispositivos para o tratamento de doenças hepáticas
KR101640381B1 (ko) 2008-02-22 2016-07-18 에이전시 포 사이언스, 테크놀로지 앤드 리서치 중간엽 줄기세포 입자
SG177467A1 (en) * 2009-07-23 2012-02-28 Agency Science Tech & Res Pre-natal mesenchymal stem cells
US20120219632A1 (en) * 2009-11-02 2012-08-30 Agency For Science, Technology And Research Methods for monitoring cellular states and for immortalizing mesenchymal stem cell
KR101189655B1 (ko) 2010-06-30 2012-10-11 성균관대학교산학협력단 줄기세포 배양액을 포함하는 폐질환 치료용 조성물
CN101890050B (zh) * 2010-07-14 2012-07-04 江苏大学 脐带间质干细胞来源膜性囊泡及其应用
EP2603592A2 (en) 2010-08-13 2013-06-19 The University Court of the University of Glasgow Therapeutic uses of microvesicles and related micrornas
EP2678448A4 (en) 2011-02-22 2014-10-01 Caris Life Sciences Luxembourg Holdings S A R L CIRCULATING BIOMARKERS
ES2629502T3 (es) * 2011-03-11 2017-08-10 Children's Medical Center Corporation Métodos y composiciones relacionados con exosomas de células madre mesenquimales
JP6450673B2 (ja) 2012-04-03 2019-01-09 リニューロン・リミテッドReNeuron Limited 幹細胞微粒子
US10624929B2 (en) 2014-05-18 2020-04-21 Children's Medical Center Corporation Methods and compositions relating to exosomes

Similar Documents

Publication Publication Date Title
JP2014507482A5 (ja)
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
JP2015525757A5 (ja)
JP2012500090A5 (ja)
CL2012001836A1 (es) Compuestos de pirazol, antagonista de crth2; composicion farmacéutica; uso en el tratamiento de trastornos inflamatorios, infecciosos, inmunoreguladores, enfermedades respiratorias, gastrointestinales o dolencias, entre otros.
JP2016014009A5 (ja)
JP2013523758A5 (ja)
JP2012512815A5 (ja)
WO2014164280A8 (en) Micronized pharmaceutical compositions
JP2019528267A5 (ja)
JP2015536999A5 (ja)
JP2013079218A5 (ja)
TR200909788A2 (tr) Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
PH12015502560B1 (en) Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease
TR201004317A2 (tr) Türbülans oluşumunu sağlayan inhalasyon cihazı.
Patterson et al. Effect Of Injured Lung Derived Inflammatory Mediators On Peripheral Organ Cells
TH93628B (th) หลอดยาดม
WO2013109213A3 (en) Pharmaceutical formulations comprising tiotropium
CN302371352S (zh) 一次性使用人体酒精测试仪(2)
CN302243804S (zh) 游艺机(超级秋千)
CN301973213S (zh) 椅子(gs-g1795b)
CN302363025S (zh) 加湿器(沙漏g0-2850)
TH119318B (th) หลอดยาดม
CN302038896S (zh) 沙发(3296)
CN302166397S (zh) 加湿器(s40u-t)